Reduce your pharmaceutical
R&D costs by 25%*
Through the utilization of our skin organoid technology
Derived from iPSc* for unlimited cell source and reproductibility
Includes multiple cell types: epidermis, dermis, hair follicles, neurons, adipocytes
Unmatched biological response for compound analysis
Fine-tune organoids to suits your biological needs
A biobank access to customizable organoids.
Disease modeling of genetic and inflammatory conditions.
Targeted research for focused efficacy analysis.
And choose our tailor-made offer for your skin compounds research
_edited.png)
Toxicity - Efficacy analysis
_edited.png)
Cell/cell interactions
_edited.png)
Inflammatory signature
_edited.png)
3D
imaging
For both pharmaceutic and
dermo-cosmetic industries
De-risk the R&D program
Enhance your success rates by multiplying outcomes 2x to 5x
From 25% to 75% in robustness
Reduce reliance on animal models
Our team
Cécile's groundbreaking research on skin organoids was further enhanced by the collaboration with Giulia, who holds a PhD in Molecular and Cellular Biology, and her co-founder Mathieu, a pharmacist with extensive experience in business development.
Together, they form a dynamic team at BioHive, driven by a passion for innovation and a commitment to advancing medical science. Our team is eager to engage with you and explore how our tailored organoid solutions can support your research and development goals.
Our Partners
